Immune evaluation and vaccine responses in Down syndrome: Evidence of immunodeficiency?

Vaccine

Volumn 29, Issue 31, 2011, Pages 5040-5046

  Joshi, Avni Y ^a   Abraham, Roshini S ^a   Snyder, Melissa R ^a   Boyce, Thomas G ^a  

^a MAYO CLINIC   (United States)

Author keywords

Cellular immunity; Humoral immunity; Immunity; Immunoglobulin; Infections; Influenza; Pneumococcal polysaccharide vaccine; Vaccine

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNIZATION; LYMPHOCYTE; LYMPHOCYTE COUNT; MALE; MEMORY CELL; PRIORITY JOURNAL; QUANTITATIVE STUDY; SCHOOL CHILD;

ADOLESCENT; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; ANTIGENS, BACTERIAL; ANTIGENS, VIRAL; CHILD; CHILD, PRESCHOOL; DOWN SYNDROME; FEMALE; HUMANS; IMMUNOLOGIC DEFICIENCY SYNDROMES; LYMPHOCYTE SUBSETS; MALE; VACCINES;

EID: 79959696116     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.04.060     Document Type: Article

References (38)

1. Irving C., Basu A., Richmond S., Burn J., Wren C. Twenty-year trends in prevalence and survival of Down syndrome. Eur J Hum Genet 2008, 16(11):1336-1340.
2. Mastroiacovo P., Bertollini R., Corchia C. Survival trends in Down syndrome. Lancet 1990, 335(8700):1278-1279.
3. Yang Q., Rasmussen S.A., Friedman J.M. Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Lancet 2002, 359(9311):1019-1025.
4. Garrison M.M., Jeffries H., Christakis D.A. Risk of death for children with Down syndrome and sepsis. J Pediatr 2005, 147(6):748-752.
5. Day S.M., Strauss D.J., Shavelle R.M., Reynolds R.J. Mortality and causes of death in persons with Down syndrome in California. Dev Med Child Neurol 2005, 47(3):171-176.
6. Bittles A.H., Bower C., Hussain R., Glasson E.J. The four ages of Down syndrome. Eur J Public Health 2007, 17(2):221-225.
7. Goldacre M.J., Wotton C.J., Seagroatt V., Yeates D. Cancers and immune related diseases associated with Down's syndrome: a record linkage study. Arch Dis Child 2004, 89(11):1014-1017.
8. de Hingh Y.C., van der Vossen P.W., Gemen E.F., Mulder A.B., Hop W.C., Brus F., et al. Intrinsic abnormalities of lymphocyte counts in children with Down syndrome. J Pediatr 2005, 147(6):744-747.
9. Comans-Bitter W.M., de Groot R., van den Beemd R., Neijens H.J., Hop W.C., Groeneveld K., et al. Immunophenotyping of blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J Pediatr 1997, 130(3):388-393.
10. Cuadrado E., Barrena M.J. Immune dysfunction in Down's syndrome: primary immune deficiency or early senescence of the immune system?. Clin Immunol Immunopathol 1996, 78(3):209-214.
11. Burgio G.R., Ugazio A.G., Nespoli L., Marcioni A.F., Bottelli A.M., Pasquali F. Derangements of immunoglobulin levels, phytohemagglutinin responsiveness and T and B cell markers in Down's syndrome at different ages. Eur J Immunol 1975, 5(9):600-603.
12. Burgio G.R., Lanzavecchia A., Maccario R., Vitiello A., Plebani A., Ugazio A.G. Immunodeficiency in Down's syndrome: T-lymphocyte subset imbalance in trisomic children. Clin Exp Immunol 1978, 33(2):298-301.
13. Levin S., Schlesinger M., Handzel Z., Hahn T., Altman Y., Czernobilsky B., et al. Thymic deficiency in Down's syndrome. Pediatrics 1979, 63(1):80-87.
14. Levin S., Nir E., Mogilner B.M. T system immune-deficiency in Down's syndrome. Pediatrics 1975, 56(1):123-126.
15. Maccario R., Ugazio A.G., Nespoli L., Alberini C., Montagna D., Porta F., et al. Lymphocyte subpopulations in Down's syndrome: high percentage of circulating HNK-1+, Leu 2a+ cells. Clin Exp Immunol 1984, 57(1):220-226.
16. Avanzini M.A., Soderstrom T., Wahl M., Plebani A., Burgio G.R., Hanson L.A. IgG subclass deficiency in patients with Down's syndrome and aberrant hepatitis B vaccine response. Scand J Immunol 1988, 28(4):465-470.
17. Kusters M.A., Verstegen R.H., Gemen E.F., de Vries E. Intrinsic defect of the immune system in children with Down syndrome: a review. Clin Exp Immunol 2009, 156(2):189-193.
18. Ip S.H., Rittershaus C.W., Healey K.W., Struzziero C.C., Hoffman R.A., Hansen P.W. Rapid enumeration of T lymphocytes by a flow-cytometric immunofluorescence method. Clin Chem 1982, 28(9):1905-1909.
19. Plikaytis B.D., Holder P.F., Pais L.B., Maslanka S.E., Gheesling L.L., Carlone G.M. Determination of parallelism and nonparallelism in bioassay dilution curves. J Clin Microbiol 1994, 32(10):2441-2447.
20. Plikaytis B.D., Goldblatt D., Frasch C.E., Blondeau C., Bybel M.J., Giebink G.S., et al. An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay study. J Clin Microbiol 2000, 38(6):2043-2050.
21. Douek D.C., Vescio R.A., Betts M.R., Brenchley J.M., Hill B.J., Zhang L., et al. Assessment of thymic output in adults after haematopoietic stem-cell transplantation and prediction of T-cell reconstitution. Lancet 2000, 355(9218):1875-1881.
22. Beyer W.E., Palache A.M., Osterhaus A.D. Comparison of serology and reactogenicity between influenza subunit vaccines and whole virus or split vaccines: a review and meta-analysis of the literature. Clin Drug Investig 1998, 15(1):1-12.
23. Costa-Carvalho B.T., Martinez R.M., Dias A.T., Kubo C.A., Barros-Nunes P., Leiva L., et al. Antibody response to pneumococcal capsular polysaccharide vaccine in Down syndrome patients. Braz J Med Biol Res 2006, 39(12):1587-1592.
24. Sorensen R.U., Hidalgo H., Moore C., Leiva L.E. Post-immunization pneumococcal antibody titers and IgG subclasses. Pediatr Pulmonol 1996, 22(3):167-173.
25. Sorensen R.U., Leiva L.E., Javier F.C., Sacerdote D.M., Bradford N., Butler B., et al. Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations. J Allergy Clin Immunol 1998, 102(2):215-221.
26. Ballow M. Primary immunodeficiency disorders: antibody deficiency. J Allergy Clin Immunol 2002, 109(4):581-591.
27. Bonilla F.A., Bernstein I.L., Khan D.A., Ballas Z.K., Chinen J., Frank M.M., et al. Practice parameter for the diagnosis and management of primary immunodeficiency. Ann Allergy Asthma Immunol 2005, 94(5 (Suppl 1)):S1-S63.
28. Kamchaisatian W., Wanwatsuntikul W., Sleasman J.W., Tangsinmankong N. Validation of current joint American Academy of Allergy, Asthma & Immunology and American College of Allergy Asthma and Immunology guidelines for antibody response to the 23-valent pneumococcal vaccine using a population of HIV-infected children. J Allergy Clin Immunol 2006, 118(6):1336-1341.
29. Douek D.C., McFarland R.D., Keiser P.H., Gage E.A., Massey J.M., Haynes B.F., et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 1998, 396(6712):690-695.
30. Kusters MA, Gemen EF, Verstegen RH, Wever PC, de Vries E. Both normal memory counts and decreased naive cells favor intrinsic defect over early senescence of Down syndrome T-lymphocytes. Pediatr Res.
31. Elsayed S.M., Elsayed G.M. Phenotype of apoptotic lymphocytes in children with Down syndrome. Immun Ageing 2009, 6:2.
32. Chinen J., Rosenblatt H.M., Smith E.O., Shearer W.T., Noroski L.M. Long-term assessment of T-cell populations in DiGeorge syndrome. J Allergy Clin Immunol 2003, 111(3):573-579.
33. Sullivan K.E. The clinical, immunological, and molecular spectrum of chromosome 22q11.2 deletion syndrome and DiGeorge syndrome. Curr Opin Allergy Clin Immunol 2004, 4(6):505-512.
34. Sullivan K.E. Chromosome 22q11.2 deletion syndrome: DiGeorge syndrome/velocardiofacial syndrome. Immunol Allergy Clin North Am 2008, 28(2):353-366.
35. Sullivan K.E., McDonald-McGinn D., Driscoll D.A., Emanuel B.S., Zackai E.H., Jawad A.F. Longitudinal analysis of lymphocyte function and numbers in the first year of life in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clin Diagn Lab Immunol 1999, 6(6):906-911.
36. Verstegen RH, Kusters MA, Gemen EF, de Vries E. Down syndrome B lymphocyte subpopulations, intrinsic defect or decreased T-lymphocyte help. Pediatr Res.
37. Nurmi T., Leinonen M., Haiva V.M., Tiilikainen A., Kouvalainen K. Antibody response to pneumococcal vaccine in patients with trisomy-21 (Down's syndrome). Clin Exp Immunol 1982, 48(2):485-490.
38. de Roux A., Schmole-Thoma B., Siber G.R., Hackell J.G., Kuhnke A., Ahlers N., et al. Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory. Clin Infect Dis 2008, 46(7):1015-1023.